Delivery Order HHSO100201600004I-75A50119F33008
Award Date 6/21/19
Potential Completion Date 9/21/22
Potential Value $5.5M
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Research Triangle Park, NC 27709, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order issued under the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) Pandemic Influenza Preparedness and Response 2016-2021 contract vehicle. The $2,064,652.60 firm fixed price contract was awarded to Glaxosmithkline, LLC to provide a range of pharmaceutical goods and services, including influenza vaccines, antiviral medications, vaccine adjuvants, and COVID-19 treatments. Glaxosmithkline, a foreign-owned...
- This is a $499,100 firm fixed price delivery order awarded by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to Glaxosmithkline, LLC. The order is for pharmaceutical goods and services under the Pandemic Influenza Preparedness and Response 2016-2021 multiple award contract. Glaxosmithkline, a foreign-owned for-profit pharmaceutical company, provides a range of products to U.S. government agencies including influenza and hepatitis...
- The U.S. government's Bureau of Administration, a civilian agency, awarded a firm fixed-price delivery order contract to GlaxoSmithKline, LLC for the provision of 2025-2026 influenza vaccines. The contract has a ceiling value of $667,575.00 and an ultimate completion date of October 9, 2025. This award is not set aside for any specific business type. GlaxoSmithKline, a foreign-owned, for-profit pharmaceutical company, has been a critical supplier of vaccines, antivirals, and medical...
- This federal contract award was issued by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a component of the U.S. Department of Health and Human Services (HHS), to Glaxosmithkline, LLC. The purpose of this delivery order task order is to procure services for storage and stability of vaccine bulk lots from prior contracts for HHS under an Indefinite Delivery, Indefinite Quantity (IDIQ) contract worth up to $2,261,160.70. The contract is a firm fixed-price arrangement...
- This is a firm fixed-price delivery order awarded by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response to Glaxosmithkline, LLC, a pharmaceutical company that provides vaccines, antivirals, and other pharmaceutical products to U.S. government agencies. The $15,769,590.00 contract is for commercial bulk lots, with no set-aside designation, and is part of the Pandemic Influenza Preparedness and Response 2016-2021 IDIQ contract. The...
- This federal contract was awarded by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response to the prime contractor Glaxosmithkline, LLC (doing business as Glaxosmithkline). The $977,025.74 fixed-price delivery order contract supports the Pandemic Influenza Preparedness and Response 2016-2021 program and is for the provision of pharmaceutical products and services related to disease prevention and treatment. Glaxosmithkline, a global...
- The U.S. Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded a delivery order valued at $7.4 million to GlaxoSmithKline, LLC for storage and stability services related to antigens and adjuvants from prior contracts during Base Period Year 3, with performance in Durham, North Carolina. The award was made on February 21, 2024, under Indefinite Delivery/Indefinite Quantity (IDIQ) contract 75A50122D000002, with an ultimate completion date...
- This is a $533,988.00 firm fixed price delivery order awarded by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to the pharmaceutical company Glaxosmithkline, LLC. The contract is part of the Pandemic Influenza Preparedness and Response 2012-2016 IDIQ, which provides for the acquisition of medical countermeasures for pandemic influenza preparedness and response efforts. The contract does not have a set-aside designation....
- This is a firm fixed price delivery order awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency, to Glaxosmithkline, LLC to provide the acquisition of egg-based influenza master and working seed lots derived from a specific candidate vaccine virus, as well as fill-finish of any existing egg-based influenza vaccines. The order has a ceiling value of $1,650,050.61 and a completion date of February 21, 2026. No set-aside designation was used....
- This federal contract award, identified as 75A50122D00002|75A50123F61006, is a delivery order under an Indefinite Delivery Indefinite Quantity (IDIQ) contract with the Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response. The purpose of this $2,045,696.98 firm-fixed-price contract is to procure storage and stability services for antigens and adjuvants from prior contracts during the second base period year. The prime contractor is...